Desheng Hu

机构：Southwest University of Political Science & Law, Sun Yat-sen University, Dalian University of Technology, Jiangxi Science and Technology Normal University, Dalian University, Second Affiliated Hospital of Jilin University, Sun Yat-sen University Cancer Center, Hubei Cancer Hospital, Union Hospital, First Affiliated Hospital of Wannan Medical College, Henan Agricultural University, Huazhong University of Science and Technology · ORCID：0000-0001-9298-5545

发表论文 113 篇 · 总被引 1944 次 · h-index 24

代表论文

• Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial (2025 · Cancer Cell · 被引 40)
• Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma (2025 · JAMA · 被引 29)
• Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial (2025 · Journal of Hematology & Oncology · 被引 27)
• Enhanced Trained Immunity in Peripheral Monocytes in Unstable Angina With Elevated High-Sensitivity C-Reactive Protein (2025 · JACC Basic to Translational Science · 被引 9)
• Abstract CT011: Penpulimab versus placebo in combination with chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A global, multicenter, randomized, double-blind, phase 3 trial (AK105-304) (2025 · Cancer Research · 被引 7)
• Evolution and Functional Diversity of GATA Transcription Factors in Filamentous Fungi: Structural Characteristics, Metabolic Regulation and Environmental Response (2025 · Microbiology Research · 被引 5)